Completed OBSERVATIONAL NCT03823859

Metabolomics of Thyroid Hormones (MATcH)

Sponsor: ETH Zurich

Conditions Central Hypothyroidism Hyperthyroidism Hypothyroidism

Interventions Blood sampling Dual energy X-ray Absorptiometry (DXA) Indirect calorimetry

Updated 11 times since 2019 Last updated: May 16, 2022 Started: Dec 12, 2018 Primary completion: Jul 28, 2021 Completion: Dec 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03823859, this observational or N/A phase trial focuses on Central Hypothyroidism and Hyperthyroidism and remains completed. Sponsored by ETH Zurich, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jun 2022 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Dec 2021 — Jun 2022 [monthly]

Active Not Recruiting
Sep 2021 — Dec 2021 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting

▶ Show 6 earlier versions

Jun 2021 — Sep 2021 [monthly]

Recruiting
Jan 2021 — Jun 2021 [monthly]

Recruiting
Nov 2020 — Jan 2021 [monthly]

Recruiting
May 2020 — Nov 2020 [monthly]

Recruiting
May 2019 — May 2020 [monthly]

Recruiting
Feb 2019 — May 2019 [monthly]

Recruiting

First recorded

Dec 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ETH Zurich
University Hospital, Basel, Switzerland

Data source: University Hospital, Basel, Switzerland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Basel, Switzerland